Member Info for Bazzaman

Yes, that's why I said unless any further contract wins. I don't think they will release results ahead of the court hearing.

Unless any further contract wins, I would not expect any further RNS until after the court hearing on 18th May. Hopefully, towards the end of May we should see their full year results and outlook although that may slip into early June.
Just my thoughts.
GLA

Doing his magic again?
GLA

Here's Elrico link.
https://lemminginvestors.blogspot.com/

In the printed version , he has mentioned it as an on-line update only.

Article posted after hours last night with a new target price of 35p at the very least.
https://www.investorschronicle.co.uk/ideas/2021/05/06/a-copper-bottomed-investment/
GLA

Simon's magic should continue once the paper version of the IC hits the streets Friday/Saturday/Monday and therefore propel this into the 140s.
GLA

https://twitter.com/OpenOrphan/status/1390208928584196100
GLA

Velo, I was on a webinar with Simon last week whereby he admitted that he is always extremely conservative in his price targets, so agree with your sentiments here.
BOL

New article this evening from Simon.
https://www.investorschronicle.co.uk/ideas/2021/05/04/profit-from-the-commodity-boom/
SP could double in value from here according to Simon, strong buy.
GLA

https://www.investorschronicle.co.uk/ideas/2021/05/04/profit-from-the-commodity-boom/
New article this evening. Target price raised from 180p to 200p, strong buy.
GLA

93p for me

Great update stoodio, have a great weekend.

Simon's last target price was upgraded from 145p to 180p. I would expect his raise to be starting with a 2.
GLA

I would expect Simon (IC) to update his target price on the back of these Q3 results. This was part of his update in Feb 21;
First-half results this week highlight these factors. Buoyed by 74 per cent increase in its average basket price to US$3,184 per ounce, Sylvania’s first half post-tax profit of US$40m was up 69 per cent higher year-on-year on 44 per cent higher revenue of US$85m. Net cash doubled to US$67m and is set to hit US$83m by 30 June 2021 after factoring in the payment of April’s US$10.7m (3.75p a share) windfall dividend.

On this basis, the £320m market capitalisation company is rated on a miserly price/earnings (PE) ratio of 4.4. Strip out forecast net cash and the cash-adjusted PE ratio is only 3.5. If that’s not a compelling enough valuation, Liberum expects net cash to swell to US$188m (£134m) by 30 June 2022 after factoring in net profits of US$117m (£83m) in the 2021/22 financial year, implying the cash-adjusted PE ratio drops to 2.2.

I would expect his update after market closes today in time for reopening on Tuesday. GLA

Sorry, forgot the link
https://twitter.com/OpenOrphan/status/1387678103644905472

Further announcements regarding the proposed Distribution in Specie will be made in due course.
Plus, Venn Life Sciences launch new web-site

https://twitter.com/OpenOrphan/status/1387727229338144769
Further announcements regarding the proposed Distribution in Specie will be made in due course.
GLA

Interesting Oral study commencement.
GLA

Hi Velo, I'm pretty thick skinned. I either filter trolls who look like they are paid to de-ramp or just ignore any comments from people that I don't agree with. I try and use my own judgement on investing and thankfully do very well so it's just noise to me. GGP is a good one, so is JLP, SLP, ORPH, SBTX and plenty of others that I have in my portfolio.
BOL